Recall Register

Device recall: DCA Systems HbA1c Reagent Kit

Class II FDA enforcement event 94021. Recall start date: . Status in the FDA record: Ongoing.

Reason for recall, in the words of FDA

The reason for the recall is that the Siemens DCA HbA1c Reagent Kit was confirmed to display a positive bias without alerting the user. The potential impact of the defect is that erroneous test results could be reported and potentially lead to incorrect patient management of glucose control. A positive bias may be observed with eleven HbA1c affected lots. Positive bias was observed when the…

Class II, in the words of FDA

a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote

Siemens Healthcare Diagnostics, Inc. started this device recall on 7 Feb 2024. The firm address in the FDA record is in Tarrytown, NY. FDA put the recall in Class II. FDA event 94021 has 1 product record. The first FDA enforcement report date is 27 Mar 2024. The record gives the status Ongoing.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Worldwide distribution - US Nationwide and the country of Taiwan.

Recalling firm

Siemens Healthcare Diagnostics, Inc., Tarrytown, NY.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 94021: product records
Recall numberProductQuantityClassStatusReport date
Z-1304-2024DCA Systems HbA1c Reagent Kit74,211 Kits (Expanded 2/28/24: additional 72,892 kits)Class IIOngoing27 Mar 2024

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class II: The middle of the three FDA recall classes.

The event in context

Device events that started in 2024
970
Share of these events in Class II
87%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
333

Other events of the firm

Official channels

Cite this page

Recall Register. FDA enforcement event 94021. https://recallregister.com/fda/ii/94021/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA device enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Worldwide distribution - US Nationwide and the country of Taiwan.
What quantity of product is in FDA event 94021?
The FDA record gives this quantity: 74,211 Kits (Expanded 2/28/24: additional 72,892 kits)
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many device recalls of 2024 have the same class?
87% of the 970 device events that started in 2024 are in Class II.